⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL391 | 0.89 | — | — | |
| SCHEMBL31669643 | 0.80 | — | — | |
| Water SCHEMBL609480 | 0.80 | — | — | |
| SCHEMBL31355123 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL567492 | 0.80 | — | — | |
| SCHEMBL21596989 | 0.80 | — | — | |
| Bromide SCHEMBL10339581 | 0.80 | — | — | |
| Water SCHEMBL2196363 | 0.80 | — | — | |
| Charcoal, Activated SCHEMBL31621000 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL11039809 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146149-A1 | ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID | The Procter & Gamble Company (US) | 2023-03-15 | — | — | EP | disclosed |
| EP-4146144-A1 | ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 2023-03-15 | — | — | EP | disclosed |
| EP-4146148-A1 | ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID | The Procter & Gamble Company (US) | 2023-03-15 | — | — | EP | disclosed |
| CN-115551468-A | Oral care compositions comprising dicarboxylic acids | 宝洁公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-115515553-A | Oral care compositions comprising dicarboxylic acids | 宝洁公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115515552-A | Oral care compositions comprising dicarboxylic acids | 宝洁公司 | 2022-12-23 | — | — | CN | disclosed |
| US-20210353516-A1 | Oral Care Compositions Comprising Dicarboxylic Acid | THE PROCTER & GAMBLE COMPANY | 2021-11-18 | — | — | US | disclosed |
| US-20210346259-A1 | Oral Care Compositions Comprising Dicarboxylic Acid | THE PROCTER & GAMBLE COMPANY | 2021-11-11 | — | — | US | disclosed |
| US-20210346260-A1 | Oral Care Compositions Comprising Dicarboxylic Acid | THE PROCTER & GAMBLE COMPANY | 2021-11-11 | — | — | US | disclosed |
| WO-2021226153-A1 | ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-2238965-A1 | Oral compositions containing stannous ions | The Procter & Gamble Company (US) | 2010-10-13 | — | — | EP | disclosed |
| EP-1227788-B1 | ORAL COMPOSITIONS CONTAINING STANNOUS IONS | PROCTER & GAMBLE (US) | 2010-08-11 | — | — | EP | disclosed |
| US-20050112070-A1 | Stannous oral compositions | THE PROCTER & GAMBLE COMPANY (US) | 2005-05-26 | — | — | US | disclosed |
| CN-1200685-C | Stannous oral compositions | PROCTER & GAMBLE (US) | 2005-05-11 | — | — | CN | disclosed |
| US-6821507-B2 | STANNOUS ION SOURCE, FLUORIDE ION SOURCE, AND A POLYMERIC MINERAL SURFACE ACTIVE AGENT THAT BINDS STANNOUS, COMPOSITIONS PROVIDING ADEQUATE THERAPEUTIC EFFICACY WITH MINIMAL SIDE EFFECTS OF TOOTH STAINING AND ASTRINGENCY | THE PROCTER & GAMBLE CO. | 2004-11-23 | — | — | US | disclosed |
| US-20030152527-A1 | Stannous oral compositions | THE PROCTER & GAMBLE COMPANY | 2003-08-14 | — | — | US | disclosed |
| CN-1420757-A | Improved stannous oral compositions | PROCTER & GAMBLE (US) | 2003-05-28 | — | — | CN | disclosed |
| US-6555094-B1 | Stannous oral compositions | THE PROCTER & GAMBLE COMPANY | 2003-04-29 | — | — | US | disclosed |
| EP-1227788-A1 | IMPROVED STANNOUS ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2001034108-A1 | IMPROVED STANNOUS ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-05-17 | — | — | WO | disclosed |